| 产品详情 |
| Edit |   |
|---|
| Product Name | LY-3200882 |
|---|
| Description | LY-3200882 is a potent and ATP-competitive inhibitor of TGF-β receptor type 1 (TGF-βRI). It inhibits TGF-β-induced SMAD phosphorylation in vitro and in vivo and exhibits antitumor activity in the 4T1-LP triple negative breast cancer orthotopic tumor model. MW: 435.53. Purity ≥98% by HPLC |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[[4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-2-pyridinyl]amino]-α,α-dimethyl-2-pyridinemethanol |
|---|
| Gene, Accession, CAS # | CAS: 1898283-02-7 |
|---|
| Catalog # | B2350-1 |
|---|
| Price | |
|---|
| Order / More Info | LY-3200882 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|